Claude Bertrand

Claude Bertrand is currently the Chairman at Symphogen A, Bertrand Vigouroux SA, Institut de Recherches Servier SAS, Alliance for Research & Innovation in Health Industries, and Eclosion2 SA. He is also an Independent Director at Maat Pharma SA, a Director at Servier IP UK Ltd., and the High Council For Evaluation of Research & Higher Education.
In addition, he holds the position of Chief Scientific & EVP-Research & Development at Les Laboratoires Servier SAS and Chief Scientific Officer at Servier SAS. Previously, Dr. Bertrand worked as the EVP-Research & Development, Scientific Director at Ipsen SA from 2009 to 2017.
He also held positions as a Director at Institut National de la Santé & de la Recherche Médicale, Splicos SAS, Pfizer Holding France SCA, Abivax SA, Pfizer (St. Louis), AstraZeneca SAS, and Ipsen Pharma SAS. Dr. Bertrand obtained a doctorate degree from the University of San Francisco and holds graduate and doctorate degrees from the University of Strasbourg.